ScinoPharm Taiwan Ltd (1789) — Long-term Investment Intensity
ScinoPharm Taiwan Ltd (1789) has a Long-term Investment Intensity of 3.8% as of December 2019. Long-term investments of NT$444.48 Million represent 3.8% of total assets of NT$11.67 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check ScinoPharm Taiwan Ltd (1789) asset resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
ScinoPharm Taiwan Ltd Long-term Investment Intensity (2013–2019)
This chart shows how ScinoPharm Taiwan Ltd's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 3.8%, reflecting long-term investments of NT$444.48 Million against total assets of NT$11.67 Billion TWD. For the complete balance sheet picture, see ScinoPharm Taiwan Ltd total assets.
Annual Long-term Investment Intensity for ScinoPharm Taiwan Ltd (2013–2019)
The table below presents the year-by-year Long-term Investment Intensity for ScinoPharm Taiwan Ltd from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read ScinoPharm Taiwan Ltd total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 3.8% | NT$444.48 Million | NT$11.67 Billion | ▲ +0.1 pp |
| 2018 | 3.7% | NT$468.12 Million | NT$12.56 Billion | ▲ +0.6 pp |
| 2017 | 3.1% | NT$391.10 Million | NT$12.70 Billion | ▲ +0.2 pp |
| 2016 | 2.8% | NT$364.09 Million | NT$12.78 Billion | ▲ +0.1 pp |
| 2015 | 2.8% | NT$338.91 Million | NT$12.22 Billion | ▲ +0.6 pp |
| 2014 | 2.2% | NT$247.60 Million | NT$11.37 Billion | ▼ -0.1 pp |
| 2013 | 2.2% | NT$258.13 Million | NT$11.48 Billion | — |